000			02261nam a22005175i 4500
001			978-3-642-17214-4
003			DE-He213
005			20140220083750.0
007			cr nn 008mamaa
008			110411s2011 gw | s |||| 0|eng d
020			_a9783642172144 _9978-3-642-17214-4
024	7		_a10.1007/978-3-642-17214-4 _2doi
050		4	_aRM1-950
072		7	_aMMG _2bicssc
072		7	_aMED071000 _2bisacsh
082	0	4	_a615 _223
100	1		_aSchwanstecher, Mathias. _eeditor.
245	1	0	_aDiabetes - Perspectives in Drug Therapy _h[electronic resource] / _cedited by Mathias Schwanstecher.
250			_aFirst.
264		1	_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2011.
300			_aXIV, 410 p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v203
520			_aEvery 5 seconds someone somewhere is diagnosed with diabetes, and every 10 seconds someone dies of it. Even worse, worldwide incidence rates still inexorably escalate. Thus, it is pressing to envisage the extent of the diabetes problem and ensure synergistic approaches aiming in alleviation of its ghastly toll. The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.
650		0	_aMedicine.
650		0	_aHuman physiology.
650		0	_aToxicology.
650		0	_aInternal medicine.
650		0	_aCytology.
650	1	4	_aBiomedicine.
650	2	4	_aPharmacology/Toxicology.
650	2	4	_aHuman Physiology.
650	2	4	_aCell Biology.
650	2	4	_aInternal Medicine.
650	2	4	_aMolecular Medicine.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783642172137
830		0	_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v203
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-642-17214-4
912			_aZDB-2-SBL
999			_c107227 _d107227